all 193756 studies found for:    ALL
Show Display Options
Rank Status Study
21 Not yet recruiting Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)
Condition: Hepatic Encephalopathy
Interventions: Other: Prospective Phase Rifaximin-α 550mg;   Other: Prospective Phase No Rifaximin-α 550mg;   Other: Retrospective Phase
22 Completed An Evaluation of Weekly Tafenoquine
Condition: Falciparum Parasitaemia
Interventions: Drug: Tafenoquine;   Drug: Mefloquine;   Drug: Placebo
23 Not yet recruiting Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Conditions: Breast Adenocarcinoma;   Estrogen Receptor Negative;   HER2/Neu Negative;   Progesterone Receptor Negative;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer;   Triple-Negative Breast Carcinoma
Interventions: Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
24 Not yet recruiting Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Other: Probiotics in the form of cheese portion
25 Recruiting Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention:
26 Not yet recruiting Evaluating the Predictive Value of EBUS ELASTOGRAPHY STRAIN Pattern Analysis in Patients With (Suspected) Lung Cancer
Condition: Lung Cancer
Intervention:
27 Withheld [Trial of device that is not approved or cleared by the U.S. FDA]
Condition:
Intervention:
28 Completed A Randomized, Double-blind, Placebo-controlled Evaluation of Increasing Doses of Weekly Tafenoquine for Chemosuppression of Plasmodium Falciparum
Condition: Malaria
Interventions: Drug: Placebo;   Drug: Tafenoquine 25mg;   Drug: Tafenoquine 50mg;   Drug: Tafenoquine 100 mg;   Drug: Tafenoquine 200 mg;   Drug: Mefloquine 250 mg
29 Not yet recruiting Effects of Varenicline in Heavy Drinking Smokers
Conditions: Cigarette Smoking;   Alcohol Consumption
Interventions: Drug: Varenicline;   Drug: Placebo pill (for varenicline);   Drug: Alcohol;   Drug: placebo beverage (for alcohol)
30 Recruiting Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery
Condition: Heart Diseases
Intervention:
31 Not yet recruiting Pain, Brain, Aging & Mobility
Conditions: Knee Pain Chronic;   Osteoarthritis
Interventions: Other: MRI Neuroimaging;   Other: Quantitative Sensory Testing;   Other: Questionnaires;   Other: Physical Function Testing
32 Recruiting Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC
Condition: Non-small Cell Lung Cancer
Interventions: Procedure: Surgery;   Radiation: SABR
33 Recruiting Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders
Condition: Movement Disorders
Intervention:
34 Recruiting Effect of Heat Exposure on Cognition in Persons With Tetraplegia
Conditions: Tetraplegia;   Hypothermia;   Mild Cognitive Impairment
Intervention: Procedure: Warm Temperature
35 Enrolling by invitation Phase I, Dose-escalating, Clinical and Pharmacokinetic Study of Humanized Сhimeric Anti-CD47 Antibody in Patients With Verified Diagnosis of Breast Cancer ( ASSIST-II )
Condition: Breast Cancer
Intervention: Drug: Antibody CD47
36 Completed Office Hysteroscopy and 3D Power Doppler Vaginal Ultrasound in Assessment of Postmenopausal Bleeding
Condition: Postmenopausal Bleeding
Interventions: Procedure: 2D grey scale vaginal ultrasound;   Procedure: 3D power Doppler vaginal ultrasound;   Procedure: Office hysteroscopy
37 Recruiting Impact of a Virtual Diabetes Self-Care and Education Program on Diabetes-related Outcomes in Latinos With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Behavioral: Virtual Diabetes Self-Care and Education Program;   Device: Fitbit;   Device: Smartphone
38 Not yet recruiting Improving Sleep and the Patient Experience in the Emergency Department
Condition: Sleep Deprivation
Interventions: Device: Sleep mask;   Other: Standard of care;   Device: Ear Plugs
39 Not yet recruiting A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358)
Condition: Various Advanced Cancer
Intervention: Drug: Nivolumab
40 Recruiting Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
Conditions: Gastric Neoplasms;   Gastrointestinal Stromal Tumors
Intervention: Device: GERDX(TM)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years